At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 162 enrolled
Drug / intervention
Tretinoin Facial Gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Investigator-Blind, Phase 4 Study Assessing the Facial Irritation Potential of Two Acne Treatment Products (Retin-A Micro Gel, 0.04% Pump and Epiduo Gel) Using a Split-Face Model
In Brief
A Phase 4 clinical trial evaluating Tretinoin Facial Gel and Adapalene/Benzoyl Peroxide Facial Gel for Acne Vulgaris. Completed, enrolled 162 participants across 1 site.
Detailed Summary
A study to compare the skin irritation potential of two marketed gels for acne treatment, each applied to half of the face of healthy volunteers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2009
First PostedAug 2009
Primary CompletionOct 2009
TodayJul 2026
First PostedAug 6, 2009
Enrollment StartJul 1, 2009
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 16.9 years ago
Interventions
Tretinoin Facial Geldrug
A marketed facial gel containing Tretinoin 0.04% is applied to one side of the face daily for three weeks.
Adapalene/Benzoyl Peroxide Facial Geldrug
A marketed facial gel containing Adapalene .1% and Benzoyl peroxide 2.5% is applied to the other side of the face daily for three weeks